Loss of the mitochondrial i-AAA protease YME1L leads to ocular dysfunction and spinal axonopathy.
- DOI
- 10.15252/emmm.201809288
- Published
- 2019 Jan
- Container
- EMBO molecular medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.15252/emmm.201809288,
title = {Loss of the mitochondrial i-AAA protease YME1L leads to ocular dysfunction and spinal axonopathy.},
author = {Sprenger HG and Wani G and Hesseling A and König T and Patron M and MacVicar T and Ahola S and Wai T and Barth E and Rugarli EI and Bergami M and Langer T},
year = {2019},
journal = {EMBO molecular medicine},
doi = {10.15252/emmm.201809288},
url = {https://doi.org/10.15252/emmm.201809288}
}RIS
TY - JOUR TI - Loss of the mitochondrial i-AAA protease YME1L leads to ocular dysfunction and spinal axonopathy. AU - Sprenger HG AU - Wani G AU - Hesseling A AU - König T AU - Patron M AU - MacVicar T AU - Ahola S AU - Wai T AU - Barth E AU - Rugarli EI AU - Bergami M AU - Langer T PY - 2019 JO - EMBO molecular medicine DO - 10.15252/emmm.201809288 UR - https://doi.org/10.15252/emmm.201809288 ER -
APA
HG, S., G, W., A, H., T, K., M, P., T, M., S, A., T, W., E, B., EI, R., M, B., & T, L. (2019). Loss of the mitochondrial i-AAA protease YME1L leads to ocular dysfunction and spinal axonopathy.. EMBO molecular medicine. https://doi.org/10.15252/emmm.201809288
Source records
- pubmed · retrieved 2026-09-26T15:46:45.920Z